Tachykinin receptor 1

From Wikipedia, the free encyclopedia


Tachykinin receptor 1
Identifiers
Symbol(s) TACR1; SPR; NK1R; NKIR; TAC1R
External IDs OMIM: 162323 MGI: 98475 HomoloGene: 20288
RNA expression pattern

More reference expression data
Orthologs
Human Mouse
Entrez 6869 21336
Ensembl ENSG00000115353 ENSMUSG00000030043
Uniprot P25103 Q3V353
Refseq NM_001058 (mRNA)
NP_001049 (protein)		 NM_009313 (mRNA)
NP_033339 (protein)
Location Chr 2: 75.13 - 75.28 Mb Chr 6: 82.37 - 82.53 Mb
Pubmed search [1] [2]

TACR1 is a G protein coupled receptor found in the central nervous system and peripheral nervous system. The endogenous ligand for this receptor is Substance P, although it has some affinity for other tachykinins. The protein is the product of the TACR1 gene.[1]

This protein is considered an attractive drug target, particularly with regards to potential analgesics and anti-depressants.[2] It was identified as a candidate in the etiology of bipolar disorder by a 2008 study.[3]

Neurokinin 1 antagonists may have a role as novel antiemetics.[4]

Contents

[edit] See also

[edit] References

  1. ^ Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE (1991). "Molecular cloning, structural characterization and functional expression of the human substance P receptor". Biochem. Biophys. Res. Commun. 179 (3): 1232–40. PMID 1718267. 
  2. ^ Humphrey JM (2003). "Medicinal chemistry of selective neurokinin-1 antagonists". Current topics in medicinal chemistry 3 (12): 1423–35. PMID 12871173. 
  3. ^ Perlis, Roy H.; Purcell, Shaun; Fagerness, Jesen; Kirby, Andrew; Petryshen, Tracey L.; Fan, Jinbo; Sklar, Pamela (2008). "Family-Based Association Study of Lithium-Related and Other Candidate Genes in Bipolar Disorder," Archives of General Psychiatry, 65(1):53-61.
  4. ^ Jordan K (2006). "Neurokinin-1-receptor antagonists: a new approach in antiemetic therapy". Onkologie 29 (1-2): 39–43. doi:10.1159/000089800. PMID 16514255. 

[edit] Further reading

  • Burcher E (1989). "The study of tachykinin receptors.". Clin. Exp. Pharmacol. Physiol. 16 (6): 539-43. PMID 2548782. 
  • Kowall NW, Quigley BJ, Krause JE, et al. (1993). "Substance P and substance P receptor histochemistry in human neurodegenerative diseases.". Regul. Pept. 46 (1-2): 174-85. PMID 7692486. 
  • Patacchini R, Maggi CA (2002). "Peripheral tachykinin receptors as targets for new drugs.". Eur. J. Pharmacol. 429 (1-3): 13-21. PMID 11698023. 
  • Saito R, Takano Y, Kamiya HO (2003). "Roles of substance P and NK(1) receptor in the brainstem in the development of emesis.". J. Pharmacol. Sci. 91 (2): 87-94. PMID 12686752. 
  • Fong TM, Yu H, Huang RR, Strader CD (1992). "The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides.". Biochemistry 31 (47): 11806-11. PMID 1280161. 
  • Fong TM, Huang RR, Strader CD (1993). "Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor.". J. Biol. Chem. 267 (36): 25664-7. PMID 1281469. 
  • Fong TM, Anderson SA, Yu H, et al. (1992). "Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.". Mol. Pharmacol. 41 (1): 24-30. PMID 1310144. 
  • Takahashi K, Tanaka A, Hara M, Nakanishi S (1992). "The primary structure and gene organization of human substance P and neuromedin K receptors.". Eur. J. Biochem. 204 (3): 1025-33. PMID 1312928. 
  • Walsh DA, Mapp PI, Wharton J, et al. (1992). "Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis.". Ann. Rheum. Dis. 51 (3): 313-7. PMID 1374227. 
  • Gerard NP, Garraway LA, Eddy RL, et al. (1991). "Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones.". Biochemistry 30 (44): 10640-6. PMID 1657150. 
  • Hopkins B, Powell SJ, Danks P, et al. (1991). "Isolation and characterisation of the human lung NK-1 receptor cDNA.". Biochem. Biophys. Res. Commun. 180 (2): 1110-7. PMID 1659396. 
  • Takeda Y, Chou KB, Takeda J, et al. (1991). "Molecular cloning, structural characterization and functional expression of the human substance P receptor.". Biochem. Biophys. Res. Commun. 179 (3): 1232-40. PMID 1718267. 
  • Giuliani S, Barbanti G, Turini D, et al. (1992). "NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype.". Eur. J. Pharmacol. 203 (3): 365-70. PMID 1723045. 
  • Ichinose H, Katoh S, Sueoka T, et al. (1991). "Cloning and sequencing of cDNA encoding human sepiapterin reductase--an enzyme involved in tetrahydrobiopterin biosynthesis.". Biochem. Biophys. Res. Commun. 179 (1): 183-9. PMID 1883349. 
  • Thöny B, Heizmann CW, Mattei MG (1995). "Human GTP-cyclohydrolase I gene and sepiapterin reductase gene map to region 14q21-q22 and 2p14-p12, respectively, by in situ hybridization.". Genomics 26 (1): 168-70. PMID 7782081. 
  • Fong TM, Cascieri MA, Yu H, et al. (1993). "Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345.". Nature 362 (6418): 350-3. doi:10.1038/362350a0. PMID 8384323. 
  • Derocq JM, Ségui M, Blazy C, et al. (1997). "Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists.". FEBS Lett. 399 (3): 321-5. PMID 8985172. 
  • De Felipe C, Herrero JF, O'Brien JA, et al. (1998). "Altered nociception, analgesia and aggression in mice lacking the receptor for substance P.". Nature 392 (6674): 394-7. doi:10.1038/32904. PMID 9537323. 

[edit] External links

 This biochemistry article is a stub. You can help Wikipedia by expanding it.
v • d • e
Transmembrane receptor: G protein-coupled receptors
Class A: Rhodopsin like
Acetylcholine (M1, M2, M3, M4, M5) - Adrenergic (α1 (A, B, D), α2 (A, B, C), β1, β2, β3) - Adrenomedullin - Anaphylatoxin (C3a, C5a) - Angiotensin (1, 2) - Apelin - Bile acid - Bombesin (BRS3, GRPR, NMBR) - Bradykinin (B1, B2) - Cannabinoid (CB1, CB2) - Chemokine - Cholecystokinin (A, B) - Dopamine (D1, D2, D3, D4, D5) - Eicosanoid (CysLT (1, 2), LTB4 (1, 2), FPRL1, OXE, Prostaglandin ((DP (1, 2), EP (1, 2, 3, 4), PGF, Prostacyclin, Thromboxane) - EBI2 - Endothelin (A, B) - Estrogen - Formyl peptide (1, L1, L2) - Free fatty acid (1, 2, 3, 4) - FSH - Galanin (1, 2, 3) - Gonadotropin-releasing hormone (1, 2) - GPR (1, 3, 4, 6, 12, 15, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 31, 32, 33, 34, 35, 37, 39, 42, 44, 45, 50, 52, 55, 61, 62, 63, 65, 68, 75, 77, 78, 79, 82, 83, 84, 85, 87, 88, 92, 101, 103, 119, 120, 132, 135, 139, 141, 142, 146, 148, 149, 150, 151, 152, 153, 160, 161, 162, 171, 172, 173, 174, 176, 177, 182) - Ghrelin - Histamine (H1, H2, H3, H4) - Kisspeptin - Luteinizing hormone/choriogonadotropin - Lysophospholipid (1, 2, 3, 4, 5, 6, 7, 8) - MAS (1, 1L, D, E, F, G, X1, X2, X3, X4) - Melanocortin (1, 2, 3, 4, 5) - MCHR (1, 2) - Melatonin (1A, 1B)- Motilin - neuromedin (B, U (1, 2)) - Neuropeptide (B/W (1, 2), FF (1, 2), S, Y (1, 2, 4, 5)) - Neurotensin (1, 2) - Opioid (Delta, Kappa, Mu, Nociceptin, but not Sigma) - Olfactory - Opsin (3, 4, 5, 1LW, 1MW, 1SW, RGR, RRH) - Orexin (1, 2) - Oxytocin - Oxoglutarate - PAF - Prokineticin (1, 2) - Prolactin-releasing peptide - Protease-activated (1, 2, 3, 4) - Purinergics (Adenosine (A1, A2a, A2b, A3), P2Y, (1, 2, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14)) - Relaxin (1, 2, 3, 4) - Somatostatin (1, 2, 3, 4, 5) - Serotonin, all but 5-HT3 (5-HT1 (A, B, D, E, F), 5-HT2 (A, B, C), 5-HT (4, 5A, 6, 7)) - SREB - Succinate - TAAR (1, 2, 3, 5, 6, 8, 9) - Tachykinin (1, 2, 3) - Thyrotropin - Thyrotropin-releasing hormone - Urotensin-II - Vasopressin (1A, 1B, 2)
Class B: Secretin like
Class C: Metabotropic
glutamate / pheromone
Calcium-sensing receptor - GABA B (1, 2) - Glutamate receptor (Metabotropic glutamate (1, 2, 3, 4, 5, 6, 7, 8)) - GPRC6A - GPR (156, 158, 179) - RAIG (1, 2, 3, 4) - Taste receptors (TAS1R (1, 2, 3) TAS2R (1, 3, 4, 5, 8, 9, 10, 12, 13, 14, 16, 38, 39, 40, 41, 43, 44, 45, 46, 47, 48, 49, 50))
Frizzled / Smoothened
Frizzled (1, 2, 3, 4, 5, 6, 7, 8, 9, 10) - Smoothened
v • d • e
Neuropeptide receptors
Hypothalamic hormone receptors
Pituitary hormone receptors
Other hormone receptors
Opioid receptors
Other neuropeptide receptors